These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18072267)

  • 21. [Abnormalities of tumor suppressor genes at chromosome 3p in lung cancer].
    Li L; An Q; Feng X
    Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):399-401. PubMed ID: 11798905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
    Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of two single nucleotide polymorphisms in von Hippel-Lindau gene and detection of loss of heterozygosity in Chinese sporadic renal cell carcinoma].
    Liu N; Gong K; Na X; Wu G; Na YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):82-4. PubMed ID: 15696489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma.
    Chino K; Esumi M; Ishida H; Okada K
    J Urol; 1999 Aug; 162(2):614-8. PubMed ID: 10411097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of somatic mutations in the von Hippel-Lindau (VHL) gene in a patient with renal cell carcinoma.
    Wang WC; Chen HJ; Tseng YH; Lai YC
    J Formos Med Assoc; 2009 Nov; 108(11):886-93. PubMed ID: 19933033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma.
    Igarashi H; Esumi M; Ishida H; Okada K
    Cancer; 2002 Jul; 95(1):47-53. PubMed ID: 12115316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent allelic loss/imbalance on the short arm of chromosome 3 in tongue cancer.
    Arai K; Shibahara T; Yamamoto N; Yakushiji T; Tanaka C; Noma H
    Bull Tokyo Dent Coll; 2001 Aug; 42(3):151-7. PubMed ID: 11806149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the FAM5C in tongue squamous cell carcinoma.
    Kuroiwa T; Yamamoto N; Onda T; Shibahara T
    Oncol Rep; 2009 Nov; 22(5):1005-11. PubMed ID: 19787213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity of the VHL gene identifies malignancy and predicts death in follicular thyroid tumors.
    Hunt JL; Yim JH; Tometsko M; Finkelstein SD; Swalsky P; Carty SE
    Surgery; 2003 Dec; 134(6):1043-7; discussion 1047-8. PubMed ID: 14668739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.
    Foster K; Prowse A; van den Berg A; Fleming S; Hulsbeek MM; Crossey PA; Richards FM; Cairns P; Affara NA; Ferguson-Smith MA
    Hum Mol Genet; 1994 Dec; 3(12):2169-73. PubMed ID: 7881415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease.
    Trimeche M; Braham H; Ziadi S; Amara K; Hachana M; Korbi S
    Oral Oncol; 2008 Aug; 44(8):775-83. PubMed ID: 18206419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma.
    Sakata K
    J Oral Pathol Med; 1996 Jul; 25(6):302-7. PubMed ID: 8887073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal cell carcinoma with leiomyomatous stroma--further immunohistochemical and molecular genetic characteristics of unusual entity.
    Peckova K; Grossmann P; Bulimbasic S; Sperga M; Perez Montiel D; Daum O; Rotterova P; Kokoskova B; Vesela P; Pivovarcikova K; Bauleth K; Branzovsky J; Dubova M; Hora M; Michal M; Hes O
    Ann Diagn Pathol; 2014 Oct; 18(5):291-6. PubMed ID: 25175809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular genetic analysis of the von Hippel-Lindau and human peroxisome proliferator-activated receptor gamma tumor-suppressor genes in adenocarcinomas of the gastroesophageal junction.
    Wijnhoven BP; Lindstedt EW; Abbou M; Ijzendoorn Y; de Krijger RR; Tilanus HW; Dinjens WN;
    Int J Cancer; 2001 Dec; 94(6):891-5. PubMed ID: 11745495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
    Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of von Hippel-Lindau tumor suppressor protein (pVHL) characteristic of tongue cancer and proliferative lesions in tongue epithelium.
    Hasegawa H; Kusumi Y; Asakawa T; Maeda M; Oinuma T; Furusaka T; Oshima T; Esumi M
    BMC Cancer; 2017 May; 17(1):381. PubMed ID: 28549422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
    Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
    Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.